A practical approach on radioprotection in the treatment of radioiodine for thyroid cancer
DOI:
https://doi.org/10.15392/bjrs.v6i3.557Palabras clave:
medical physics, radioiodine, radioprotectionResumen
There are several protocols for the treatment and follow-up of differentiated thyroid cancer. All of them gather evidence on the evolution and treatment and try to establish a treatment standard. However, there are few occasions in which this issue is addressed from the standpoint of radiological protection, as the ICRP 94 and TECDOC 1608. The focus of our work is to demonstrate that simple actions in the routine of workers in the Nuclear Medicine Service interfere positively in the radiation protection of all those involved in the patient's care, also optimizing their well being during the procedure. In the current model, the patient participates in an interview with nurses, doctors and physicists, before admission, and receives written and verbal information about the treatment procedures in order to diminish his anxiety and clarify possible doubts. In all the cases under hospital care there were no instances of high exposure (above 1mSv/month or 6 mSv/year) among the staff. With the participation of all involved, there was an escalating improvement in the reduction of complications generated by the patient’s anxiety, waste decrease, providing better comfort during hospital care) and minimization of occupational hazard affecting the staff in charge of the patient’s room maintenance after hospital leave.
Descargas
Referencias
INCA - Instituto Nacional de Câncer - Estimativa 2018 - Síntese de Resultados e Comentários. Available at: <http://www.inca.gov.br/estimativa/2018/sintese-de-resultados-comentarios.asp>. Accessed in: 18 maio. 2018.
SCHLUMBERGER; FILETTI; HAY. Nontoxic goiter and thyroid neoplasia. In: MELMED, S. et al. (Eds.). Williams textbook of endocrinology. 13th edition ed. Philadelphia, PA: Elsevier, 2016. p. 457–490.
MACIEL, R. M. B.; BISCOLLA, R. P. M.. Diagnóstico e tratamento do câncer de tiróide. In: Vilar L (editor). Endocrinologia Clinica. 3ª ed. Rio de Janeiro: Medsi, 2006. p. 240-52.
SHERMAN, S.. Thyroid carcinoma. Lancet, 2003. 361:501-11.
SEIDLIN, S.M., MARRINELLI, L.D., OSHRY, E.. Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of thyroid, JAMA 132 (1946) p. 838-847.
INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION; INTERNATIONAL ATOMIC ENERGY AGENCY. Release of patients after radionuclide therapy. Vienna, Austria: International Atomic Energy Agency, 2009.
PRYMA, D. A.; MANDEL, S. J. Radioiodine Therapy for Thyroid Cancer in the Era of Risk Stratification and Alternative Targeted Therapies. Journal of Nuclear Medicine, v. 55, n. 9, p. 1485–1491, 1 set. 2014.
Haugen, B, R. et al.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, v26, n.1 Special Article, 2016.
PACINI, F.; SCHLUMBERGER, M.; DRALLE, H.; ELISEI, R.; SMIT, JWA.; WIERSINGA, W. M. and the EUROPEAN THYROID CANCER TASKFORCE. Consensus Statement. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol, 2006. 154:787-803.
INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION (ICRP). Release of Patients after Therapy with Unsealed Radionuclides. ICRP Publication 94. Ann. ICRP 34 (2). 2004
INTERNATIONAL ATOMIC ENERGY AGENCY (IAEA). Nuclear Medicine in Thyroid Cancer Management: A Practical Approach. IAEA Tecdoc Series No. 1608. 2009b.
MOREIRA, M. A.; MASINI, E. F. S.; Aprendizagem significativa a teoria de David Ausubel. Ed.Moraes LTDA: São Paulo, 1992.
COMISSÃO NACIONAL DE ENERGIA NUCLEAR (CNEN). NN 3.01. Resolução 164/14, Diretrizes básicas de radioproteção. Rio de Janeiro, RJ: CNEN, 2014.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2021 Brazilian Journal of Radiation Sciences (BJRS)

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Licencia: los artículos de BJRS tienen una licencia internacional Creative Commons Attribution 4.0, que permite el uso, el intercambio, la adaptación, la distribución y la reproducción en cualquier medio o formato, siempre que se otorgue el crédito correspondiente al autor o autores originales y a la fuente, proporcione un enlace a la licencia Creative Commons e indique si se realizaron cambios. Las imágenes u otros materiales de terceros en el artículo están incluidos en la licencia Creative Commons del artículo, a menos que se indique lo contrario en una línea de crédito al material. Si el material no está incluido en la licencia Creative Commons del artículo y su uso previsto no está permitido por la regulación legal o excede el uso permitido, el autor deberá obtener el permiso directamente del titular de los derechos de autor. Para ver una copia de esta licencia, visite http://creativecommons.org/licenses/by/4.0/